TILT Biotherapeutics
is a Finland-based clinical-stage biotechnology company that develops oncolytic immunotherapies for the treatment of cancer... Read moreTILT Biotherapeutics
is a Finland-based clinical-stage biotechnology company that develops oncolytic immunotherapies for the treatment of cancer... Read more
News
Sep 09, 2024
Life Care News
TILT Biotherapeutics: TILT Biotherapeutics Presents Clinical Data on TILT-123
May 28, 2024
Clinical Trials Arena
TILT Biotherapeutics: TILT Biotherapeutics reports data from Phase I trial of ovarian cancer treatment
May 28, 2024
StreetInsider
Press Release: TILT Biotherapeutics : TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024
Apr 10, 2024
StreetInsider
Press Release: TILT Biotherapeutics : TILT Biotherapeutics Presents Clinical Data on TILT-123 in Combination with KEYTRUDA (pembrolizumab) for Ovarian Cancer at AACR 2024
Feb 15, 2024
Pharmabiz
TILT Biotherapeutics: TILT Biotherapeutics to receive USD 2 mn grant from US Department of Defense for a threeyear project for ovarian cancer treatment
Feb 14, 2024
BioSpace
TILT Biotherapeutics: TILT Biotherapeutics Awarded USD 2M Grant from US Department of Defense for Ovarian Cancer Immunotherapy Research
Dec 08, 2023
StreetInsider
Press Release: TILT Biotherapeutics : TILT Biotherapeutics Announces Positive Clinical Data in Checkpoint Resistant Metastatic Melanoma Phase I Trial at ESMO Immuno-Oncology 2023
Nov 06, 2023
GlobeNewswire
Press Release: TILT Biotherapeutics : TILT Biotherapeutics Announces Positive Clinical Data on Lead Asset TILT-123 at Society for Immunotherapy of Cancer 2023
May 15, 2023
BioPharma-Reporter
TILT Biotherapeutics: TILT Biotherapeutics doses first patient in cancer trial
Feb 07, 2023
BioPharma-Reporter
TILT Biotherapeutics: Finland's TILT raises 22m to progress cancer therapies
TILT Biotherapeutics Competitors
1
2
3
4
5
6
7
8
9
10